欧康医药 (833230.BJ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(欧康医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 91,517,316.4964,068,293.7768,240,881.1273,028,535.3057,555,852.5453,300,998.5158,924,811.64
 营业收入(元) 91,517,316.4964,068,293.7768,240,881.1273,028,535.3057,555,852.5453,300,998.5158,924,811.64
二、营业总成本(元) 83,213,237.9059,075,372.6859,113,846.3769,224,582.0656,044,293.2649,392,615.5853,744,632.73
 营业成本(元) 73,131,144.3451,292,779.5753,466,163.6861,483,304.8149,994,528.0543,675,805.1948,201,265.07
 研发费用(元) 4,617,003.491,788,581.512,619,655.802,780,539.263,424,605.513,822,147.533,482,350.98
 营业税金及附加(元) 5.92808,798.2536,051.58242,238.4538,900.27222,290.9790,094.34
 销售费用(元) 1,550,932.441,061,492.54316,262.361,073,088.46461,447.24249,690.88425,494.38
 管理费用(元) 3,714,677.304,257,755.682,475,394.534,004,429.492,261,792.791,733,728.801,947,022.71
 财务费用(元) 199,474.41-134,034.87200,318.42-359,018.41-136,980.60-311,047.79-401,594.75
  其中:利息费用(元) 183,044.9351,057.35102,954.33-108,741.87138,941.55297,331.97108,996.53
  其中:利息收入(元) -234,579.60199,228.91-85,073.27197,333.45353,004.341,818,604.63-677,295.07
 资产减值损失(元) -1,553,004.38---815,052.53---
 信用减值损失(元) -421,512.001,013,855.41126,445.50-1,162,721.04167,765.00--
三、其他经营收益
 加:公允价值变动收益(元) -21,923.7869,502.35973,841.1183,600.00--
 加:投资收益(元) 185,228.59345,027.68348,851.74-305,845.78425,574.36457,293.92351,054.92
 汇兑收益(元) 21,059.38-5,217.36309,669.30-331,712.02-6,813.38638,797.42137,200.42
 资产处置收益(元) -606,227.4381,250.03-110,711.94-1,965.62-27,086.76-97.62-25,806.79
 其他收益(元) 620,461.92902,003.44448,633.061,842,501.31127,394.92522,614.25227,455.28
四、营业利润(元) 6,458,658.546,902,665.1510,319,424.764,002,998.672,281,993.424,630,720.975,870,082.74
 加:营业外收入(元) 442.48-1,565.00---2,577.492,820.99
 减:营业外支出(元) ---24,525.50---
五、利润总额(元) 6,459,101.026,739,924.0110,320,989.763,978,473.172,278,201.424,628,143.485,872,903.73
 减:所得税费用(元) 829,455.891,676,662.851,759,101.29158,840.69-135,984.395,560.17249,596.23
六、净利润(元) 5,629,645.135,063,261.168,561,888.473,819,632.482,414,185.814,622,583.315,623,307.50
(一)按经营持续性分类
  持续经营净利润(元) 5,629,645.135,063,261.168,561,888.473,819,632.482,414,185.814,622,583.315,623,307.50
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 5,678,588.175,192,563.838,654,939.614,010,232.662,414,185.814,622,583.315,623,307.50
  少数股东损益(元) -48,943.04-129,302.67-93,051.14----
 扣除非经常性损益后的净利润(元) 5,298,910.564,624,075.548,139,646.772,862,567.652,023,536.123,738,807.965,151,111.76
七、每股收益
 一、基本每股收益(元) 0.080.070.110.050.030.070.07
 二、稀释每股收益(元) 0.080.070.110.050.030.070.07
八、其他综合收益(元) -26,148.19------
 归属于母公司股东的其他综合收益(元) -26,148.19------
九、综合收益总额(元) 5,603,496.945,139,232.128,561,888.473,795,798.012,414,185.814,622,583.315,623,307.50
 归属于母公司所有者的综合收益总额(元) 5,652,439.985,268,534.798,654,939.613,991,165.082,414,185.814,622,583.315,623,307.50
 归属于少数股东的综合收益总额(元) -48,943.04-129,302.67-93,051.14----
公告日期 2024-10-302024-08-272024-04-262024-04-172023-10-302023-08-242023-04-26
审计意见(境内) 标准无保留意见

前瞻产业研究院